Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity: Clinical and Prognostic Implications
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is an interventional study for patients who had developed Anthracycline-Induced Cardiotoxicity (AIC) during or after anthracycline-containing therapy, referred to the Cardioncology Unit for heart failure treatment
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients who developed AIC during or after anthracycline-containing therapy assessed by LVEF valuation by echocardiography.
Locations
Other Locations
Italy
European Institute of Oncology
RECRUITING
Milan
Contact Information
Primary
Daniela Cardinale, MD
daniela.cardinale@ieo.it
+39 0257489748
Time Frame
Start Date: 2018-02-22
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 100
Treatments
Other: Evaluation of myocardial fibrosis
Echocardiogram with left ventricular ejection fraction (LVEF) evaluation (biplane method) and CMR with contrast media agent
Related Therapeutic Areas
Sponsors
Leads: European Institute of Oncology